Check with HR or the plan document for indication-specific coverage
Unfortunately, Sanofi recently ran into a technical glitch that will delay its lixisenatide-Lantus fix-flex device from starting phase 3 trials in the first half of 2013
Glucose [161] and other carbohydrates such as d-allulose [162], Astragalus polysaccharide (APS) [163], polysaccharides from Dendrobium officinale [164], indigestible polysaccharides resistant maltodextrin (RMD) [165], -glucan or arabinoxylan [166], and enzymatically-synthesized glycogen [167]stimulate GLP-1 secretion by utilizing glucose sensors, including sweet taste receptors (STRs), sodium-glucose transporter 1 (SGLT-1), and monosaccharide transporter [168, 169] (Fig
The development of dependable biomarkers to estimate therapy response and enhance patient selection constitutes another substantial unmet need, since individual responses to GLP-1 treatments might differ markedly
GLP-1 and hair loss: causes, prevention, and what helps